missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Everolimus, MedChemExpress
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
Description
Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities.
Specifications
Specifications
| Chemical Name or Material | Everolimus |
| Physical Form | Powder |
| CAS | 159351-69-6 |
| Color | White |
| Quantity | 10 mg |
| Purity Grade Notes | Research |
| Molecular Formula | C53H83NO14 |
| For Use With (Application) | Cancer-Kinase/protease |
| Synonym | RAD001 SDZ-RAD |
| Solubility Information | DMSO : ≥ 54 mg/mL (56.35 mM) ∣H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble) |
| Show More |
Research purposes only
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction